Not a week seems to go by without a CRO sale rumor, and now the Wall Street Journal is adding Parexel to that list.

Asia-Pacific CRO George Clinical has topped up its cancer services and boosted its U.S. presence after acquiring Memphis, Tennessee-based Vector Oncology'…

The Abu Dhabi Investment Authority and Singapore’s GIC have bought a minority stake in PPD, valuing the CRO giant at more than $9 billion.

Ion channel CRO Metrion Biosciences has reached a collaboration agreement with Venomtech to utilize the latter’s venom library in search of novel ion channel…

NCGS is expanding its business by relocating to a new corporate headquarters, bringing $10 million in investment and creating 80 new jobs.

After raising $31 million just last year, California-based clinical research company Science 37 has now served up a Series C round worth $29 million.

Medidata is acquiring Mytrus, together with its industry-first electronic informed consent service.

U.K.-based CRO Chiltern has put itself up for sale as it continues the bullish M&A run for contract research groups that has seen a host of deals, JVs and…

Texas-based Moleculin Biotech penned a deal with Theradex Systems to help it run early-stage trials for its candidate annamycin in acute myeloid leukemia.

Takeda is nearing the final stages of a joint venture with PRA Health Sciences, the product of an expansion of their clinical development partnership in Japan…

Deals